Refine Results
- Applications and Industries
- Content Type
- Analysis Platform
- Language
- Publication Date
1 - 20 of 31 results
Applied Filters
必威体育登录手机In this technical overview, we embedded a single HT-1080 tumor spheroid into extracellular matrix, using the 3D spheroid invasion module of the Agilent xCELLigence RTCA eSight system to continuously acquire brightfield and fluorescent channel images...
Using real-time cell potency and bioenergetic assays to optimize critical process parameters for manufacturing of engineered T cells.
Using real-time cell potency and bioenergetic assays to optimize critical process parameters for manufacturing of engineered T cells with eSight and Seahorse technology.
This application note demonstrates the signal recording of the xCELLigence RTCA eSight, enabling visualization and quantification of cell migration and invasion and the speed of wound closure healing.
This application note describes a novel real-time co-culture assay using RTCA eSight for interrogating NK92 immune cell invasion and cytotoxicity and migratory kinetic profiles based on ECM and effects of TME.
Multiparametric real-time automated readouts using simultaneous cellular impedance and live cell imaging.
必威体育登录手机Technical overview describes a method for monoclonal cell isolation using a live cell analysis system, the Agilent xCELLigence RTCA eSight, with a limiting dilution cloning method.
必威体育登录手机This application note evaluates the Agilent xCELLigence RTCA eSight as a tool to monitor BiTE antibody-mediated cancer cell lysis.
The eSight platform provides an efficient way to dynamically monitor immune cell activation and clustering to advance tumor immunotherapy development.Here, we evaluate CAR-T and NK92 cell killing efficacy.
This application note describes pulse labeling methods based on inorganic quantum dots, organic nanoparticles, dyes that covalently modify cytoplasmic proteins, and baculovirus.After evaluating each reagent's labeling efficiency across a population...
This tech note demonstrates the ability of the RTCA eSight assay to identify and characterize antiviral drugs using adenovirus as a model system in real time.
Measure and quantify enhanced immune cell cancer killing with antibody drug treatment!shown here is a combo of trastuzumab and PBMCs targeting HER-2 positive cells
必威体育登录手机The Agilent xCELLigence RTCA eSight monitors 3D tumor spheroid growth/shrinkage in real time using brightfield plus red, green, and blue fluorescence.
必威体育登录手机A demonstration of how the Agilent xCELLigence RTCA eSight can be used to identify and characterize virus neutralizing antibodies in real-time.
The xCELLigence eSight was used to continuously monitor CAR T cell-mediated killing of cancer cells.
必威体育登录手机A demonstration of how the Agilent xCELLigence RTCA eSight real-time imaging platform can be used to monitor induction of the unfolded protein response using a genetically encoded fluorescent sensor.
必威体育登录手机A demonstration of how the Agilent xCELLigence RTCA eSight real-time imaging platform can be used to monitor phagocytosis, using a model system comprising macrophages and E.coli cells conjugated to a pH-sensitive fluorescent dye.
必威体育登录手机A demonstration of how the Agilent xCELLigence RTCA eSight can be used to identify and characterize virus neutralizing antibodies in real-time
A demonstration of how the eSight combines the strengths of real-time impedance monitoring with those of live cell imaging, to increase the information richness of your proliferation assays while simultaneously reducing the workload.
必威体育登录手机Using the Agilent xCELLigence RTCA eSight to continuously monitor CAR T cell-mediatedkilling of cancer cells over the course of multiplae days.